160 related articles for article (PubMed ID: 20523089)
1. Surgical debulking before or after chemotherapy: stemming the tide on ovarian cancer recurrence.
Rueda BR; Tilly JL; Schorge JO
Onkologie; 2010; 33(6):286-7. PubMed ID: 20523089
[No Abstract] [Full Text] [Related]
2. Residual cancer stem cells after interval cytoreductive surgery following neoadjuvant chemotherapy could result in poor treatment outcomes for ovarian cancer.
Lim MC; Song YJ; Seo SS; Yoo CW; Kang S; Park SY
Onkologie; 2010; 33(6):324-30. PubMed ID: 20523098
[TBL] [Abstract][Full Text] [Related]
3. The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancer.
Huober J; Meyer A; Wagner U; Wallwiener D
J Cancer Res Clin Oncol; 2002 Mar; 128(3):153-60. PubMed ID: 11935302
[TBL] [Abstract][Full Text] [Related]
4. [Secondary debulking after dose-intensified chemotherapy of ovarian carcinoma].
Meier W; Gropp M; Burges A; Hepp H
Praxis (Bern 1994); 1999 Mar; 88(12):519-25. PubMed ID: 10235027
[TBL] [Abstract][Full Text] [Related]
5. Impact of Pelvic and Para-aortic Lymphadenectomy in Advanced Ovarian Cancer After Neoadjuvant Chemotherapy.
Schwartz L; Schrot-Sanyan S; Brigand C; Baldauf JJ; Wattiez A; Akladios C
Anticancer Res; 2015 Oct; 35(10):5503-9. PubMed ID: 26408716
[TBL] [Abstract][Full Text] [Related]
6. [Neo-adjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer treatment--a retrospective study].
Tkácová M; Vertaková-Krakovská B; Belohorská B; Miskovská V; Helpianska L; Ondrus D; Ondrusová M; Spánik S; Svec J
Klin Onkol; 2009; 22(6):273-7. PubMed ID: 20099745
[TBL] [Abstract][Full Text] [Related]
7. LTE-commenting on "Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer" (90: 163-9).
Eisenkop SM
Gynecol Oncol; 2004 Mar; 92(3):1017-8; author reply 1018-9. PubMed ID: 14984983
[No Abstract] [Full Text] [Related]
8. [Neoadjuvant chemotherapy in the treatment of ovarian cancer].
Lehoczky O
Orv Hetil; 2005 Sep; 146(38):1951-5. PubMed ID: 16238247
[TBL] [Abstract][Full Text] [Related]
9. [Standard of chemotherapy in ovarian cancer].
Pfleiderer A; Meerpohl HG
Chirurg; 1994 Jan; 65(1):18-22. PubMed ID: 8149794
[No Abstract] [Full Text] [Related]
10. Neoadjuvant chemotherapy for ovarian cancer: clarifying the confusion.
Wallach RC
Oncology (Williston Park); 2008 Nov; 22(13):1456; author reply 1456-7. PubMed ID: 19133602
[No Abstract] [Full Text] [Related]
11. [Neoadjuvant chemotherapy for advanced epithelial ovarian cancer].
Hatae M; Onishi Y; Nakamura T; Yamamoto H; Kusumoto M; Matsui T; Mihara K; Taniguchi H
Gan To Kagaku Ryoho; 2001 Nov; 28(12):1833-7. PubMed ID: 11729475
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy in ovarian cancer.
Park TW; Kuhn WC
Expert Rev Anticancer Ther; 2004 Aug; 4(4):639-47. PubMed ID: 15270667
[TBL] [Abstract][Full Text] [Related]
13. The optimal debulking after neoadjuvant chemotherapy in ovarian cancer: proposal based on interval look during upfront surgery setting treatment.
Onda T; Yoshikawa H; Yasugi T; Matsumoto K; Taketani Y
Jpn J Clin Oncol; 2010 Jan; 40(1):36-41. PubMed ID: 19820253
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of postoperative morbidities in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy and delayed primary surgical debulking.
Le T; Alshaikh G; Hopkins L; Faught W; Fung MF
Ann Surg Oncol; 2006 Dec; 13(12):1711-6. PubMed ID: 17009146
[TBL] [Abstract][Full Text] [Related]
15. Staging and surgical treatment.
Leitao MM; Barakat RR
Cancer Treat Res; 2009; 149():35-61. PubMed ID: 19763430
[No Abstract] [Full Text] [Related]
16. The lack of significance of Ca125 response in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy and delayed primary surgical debulking.
Le T; Hopkins L; Faught W; Fung-Kee-Fung M
Gynecol Oncol; 2007 Jun; 105(3):712-5. PubMed ID: 17400284
[TBL] [Abstract][Full Text] [Related]
17. [Update on current care guidelines: ovarian cancer].
Leminen A; Auranen A; Bützow R; Hietanen S; Komulainen M; Kuoppala T; Mäenpää J; Puistola U; Vuento M; Vuorela P; Yliskoski M
Duodecim; 2012; 128(12):1300-1. PubMed ID: 22822606
[TBL] [Abstract][Full Text] [Related]
18. [Ovarian cancer from the standpoint of medical oncology].
Kato Y; Katsumata N
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1017-21. PubMed ID: 17637538
[TBL] [Abstract][Full Text] [Related]
19. The position of neoadjuvant chemotherapy within the treatment of ovarian cancer.
Van Gorp T; Amant F; Neven P; Berteloot P; Leunen K; Vergote I
Minerva Ginecol; 2006 Oct; 58(5):393-403. PubMed ID: 17006426
[TBL] [Abstract][Full Text] [Related]
20. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S;
J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]